“…Use of thirdgeneration cephalosporins, which appear to be an alternative for severe invasive disease and in children with infected with human immunodeficiency virus (HIV) or malnutrition in subSaharan Africa 2, 4, 26 is limited by its high cost in countries such as Mozambique. Factors such as incomplete compliance with antibiotic therapy, which is a well-known determinant of resistance in developing countries 14,15 and is thought to be common in the area; molecular mechanisms of resistance or the presence of genetic elements such as plasmids or integrons; 12,13 and migration, particularly to South Africa, which is common in this community, 27 may contribute to global high global level of resistance found in this study.…”